1. Home
  2. NMRA vs STRW Comparison

NMRA vs STRW Comparison

Compare NMRA & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • STRW
  • Stock Information
  • Founded
  • NMRA 2019
  • STRW 2015
  • Country
  • NMRA United States
  • STRW United States
  • Employees
  • NMRA N/A
  • STRW N/A
  • Industry
  • NMRA
  • STRW Real Estate Investment Trusts
  • Sector
  • NMRA
  • STRW Real Estate
  • Exchange
  • NMRA Nasdaq
  • STRW Nasdaq
  • Market Cap
  • NMRA 112.8M
  • STRW 133.6M
  • IPO Year
  • NMRA 2023
  • STRW N/A
  • Fundamental
  • Price
  • NMRA $0.73
  • STRW $10.22
  • Analyst Decision
  • NMRA Buy
  • STRW Strong Buy
  • Analyst Count
  • NMRA 8
  • STRW 4
  • Target Price
  • NMRA $9.29
  • STRW $13.83
  • AVG Volume (30 Days)
  • NMRA 846.2K
  • STRW 50.7K
  • Earning Date
  • NMRA 05-12-2025
  • STRW 05-09-2025
  • Dividend Yield
  • NMRA N/A
  • STRW 5.49%
  • EPS Growth
  • NMRA N/A
  • STRW 34.22
  • EPS
  • NMRA N/A
  • STRW 0.58
  • Revenue
  • NMRA N/A
  • STRW $126,557,000.00
  • Revenue This Year
  • NMRA N/A
  • STRW $15.21
  • Revenue Next Year
  • NMRA N/A
  • STRW $2.21
  • P/E Ratio
  • NMRA N/A
  • STRW $17.69
  • Revenue Growth
  • NMRA N/A
  • STRW 22.41
  • 52 Week Low
  • NMRA $0.61
  • STRW $8.70
  • 52 Week High
  • NMRA $17.19
  • STRW $12.90
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 45.93
  • STRW 47.46
  • Support Level
  • NMRA $0.66
  • STRW $9.46
  • Resistance Level
  • NMRA $0.73
  • STRW $10.75
  • Average True Range (ATR)
  • NMRA 0.06
  • STRW 0.63
  • MACD
  • NMRA 0.01
  • STRW 0.04
  • Stochastic Oscillator
  • NMRA 59.70
  • STRW 54.20

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About STRW Strawberry Fields REIT Inc.

Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.

Share on Social Networks: